InMed Pharmaceuticals Signs Definitive Agreement to Acquire BayMedica, a Leading Commercial Manufacturer of Rare Cannabinoids
Establishes leadership position in manufacturing and commercialization of rare cannabinoids
Positions InMed within large and growing consumer health and wellness cannabinoid markets
Transitions InMed into revenue generating company; acquires pipeline with numerous planned product launches